Headquartered in Clamart just outside Paris, France, our precise technologies are manufactured in France, Italy and the Dominican Republic.
Using the latest breakthrough technology and state-of-the-art manufacturing processes,
MicroPort® CRM develops solutions to help physicians better treat cardiac rhythm disorders and heart failure.
Intelligent algorithms in our devices ensure precise detection and treatment of arrhythmias, optimized pacing therapy and efficient management of multiple conditions.
With over 300 products currently approved for use in over 8,000 hospitals worldwide, MicroPort is contributing to a better world through its life-saving medical therapies and quality-improving care devices being used in patients every 12 seconds.
The quality of MicroPort products is of paramount importance – “Eyes for greatness, hands on details” is the company creed that every MicroPort® employee shares.
With a large global footprint of R&D and manufacturing facilities in Shanghai, Jiangsu, Zhejiang, Beijing, and Shenzhen in China; Memphis, TN in the US; Clamart in France; Saluggia in Italy; and Santo Domingo in Dominican Republic, a strong focus on technology innovation with over 3,500 issued patents, and a global workforce of over 4,500 employees, MicroPort® is committed to its vision of being a patient-oriented company capable of leading the future of minimally invasive healthcare and other emerging technologies.
Over the past few decades, the pioneers of MicroPort have devoted themselves to the mission of advancing the forefront of technology innovation to develop the best and most affordable medical therapies to treat patients around the globe.
Through years of growth and innovation, MicroPort® has become a premier medical solution provider covering 10 major medical disciplines including interventional cardiology, orthopedics, cardiac rhythm management, electrophysiology, endovascular, neurovascular and diabetes.
For more information please visit microport.com